Dawn Halkuff sold $309K of Xeris Biopharma (XERS)

Executed Aug 12 2025, disclosed Aug 13 2025, 1 day later.

Value, as filed

$309K

42,500 sh × $7.28

Executed

Aug 12 2025

the trade date, as filed

Disclosed

Aug 13 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DH Dawn Halkuff Director profile →

Dawn Halkuff (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $122K of XERS (20,000 sh × $6.09, as filed), executed Jun 4.

The name

XERS Xeris Biopharma Holdings, Inc. XERS · Healthcare · 26 filings in 24 months ticker →

Healthcare · Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chron…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Dawn Halkuff in XERS

XERSSALE Xeris Biopharma Holdings, Inc. $122K
20,000 sh × $6.09
Exec Jun 4
Filed Jun 5 · 5:30 PM ET